logo

Sector: Chemicals & Petrochemicals

|

Small Cap

Tatva Chintan Pharma Share Price

Tatva Chintan Pharma Chem Ltd.

1,224

29.60(2.48%)

Invest in TATVA with up to 2.22x margin.

Trade with MTF
23rd Feb 2026 | 3:28 PM
NSE : TATVA
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Tatva Chintan Pharma Performance

Price Movement

₹1224.00

₹1190.10

₹1243.00

Today's LowToday's High

1 Year Performance

₹1224.00

₹621.00

₹1610.00

52 Week Low52 Week High

Markets Today

High₹1,243.00
Low₹1,190.10
Open at₹1,208.80
Prev Close₹1,194.40
Volumes53.00 K
Avg Price₹1,219.57
Lower Circuit₹955.60
Upper Circuit₹1,433.20

Historical Performance

3M High₹1,523.00
3M Low₹1,071.90
1 Yr High₹1,610.00
1 Yr Low₹621.00
3 Yr High₹1,985.00
3 Yr Low₹621.00
5 Yr High₹2,977.80
5 Yr Low₹621.00

Tatva Chintan Pharma Fundamentals

Market Cap
Below industry Median
2,859.90 Cr.
PE Ratio (TTM)
High in industry
87.30
Dividend Yield
Low in industry
0.10
Net Profit TTM
129.1% incr over last year
32.76
Net Profit Growth
129.1% incr over last year
32.76
PEG Ratio
Above industry Median
0.70
ROE
81% decr over last year
0.77
Operating Revenue TTM
479.58
Operating Revenue Growth
28.5% incr over last year
Book Value
Below industry Median
3.80
MFI
MFI is mid-range
58.06
RSI
RSI is mid-range
46.89
EPS (TTM)
2.44
Debt to Equity
0.05
Face Value
10
Operating Profit Margin Qtr.
8.89
Operating Profit Qtr.
25.48
Net Profit Qtr.
15.16
Operating Revenue Qtr.
131.33
PB Ratio
3.80

Tatva Chintan Pharma Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue138.59115.86109.18107.6584
Operating Expense111.9794.7594.1199.7478.35
Operating Profit26.6221.1115.077.905.65
Depreciation9.079.058.977.266.92
Interest0.490.510.410.390.42
Tax2.813.401.920.46-0.49
Net Profit15.988.945.131.10-1.16

Tatva Chintan Pharma Technicals

Tatva Chintan Pharma Chem Ltd. EMA & SMA

1224.00

29.60 (2.48%)

Bullish Moving Average

10

Bearish Moving Average

6

Day EMA5 ₹1206.5
Day EMA10 ₹1202.3
Day EMA12 ₹1202.4
Day EMA20 ₹1211.4
Day EMA26 ₹1222.4
Day EMA50 ₹1257.8
Day EMA100 ₹1253.2
Day EMA200 ₹1179.3

Tatva Chintan Pharma Support and Resistance

Resistance

First Resistance₹1229.13
Second Resistance₹1263.87
Third Resistance₹1284.73

Support

First Support₹1173.53
Second Support₹1152.67
Third Support₹1117.93

Technical Indicators

Day RSI46.89
Day MFI58.06
Day ADX13.43
Day Commodity Channel Index57.70
William-51.31
Day MACD-19.98
Day MACD Signal Line-30.04
Day ATR62.69
Day ROC1259.18
Day ROC21-6.19

Tatva Chintan Pharma Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter727272727272
FII3.33.43.33.33.44.2
DII6.96.35.55.13.93.3
Public17.818.319.219.620.720.5

Tatva Chintan Pharma Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day29.67 K67.26 K44.12%
Week21.32 K51.71 K41.24%
1 Month38.84 K1.23 L31.49%
6 Month44.23 K1.57 L28.09%

Tatva Chintan Pharma SWOT Analysis

Strengths20
Weakness11
Opportunity6
Threats1

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Companies with rising net profit margins - quarterly as well as TTM basis

Companies with Net Profit TTM 5X that of Net Profit in Previous Year

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 4 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Top Gainers

Insiders bought stocks

Tatva Chintan Pharma Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
12 Sep, 20251FINAL12 Sep, 2025Equity Share
06 Sep, 20242FINALEquity Share
08 Sep, 20232FINALEquity Share
08 Sep, 20222FINAL09 Sep, 2022Equity Share

Tatva Chintan Pharma Stock Comparison

Financials
Price (₹)₹39.16₹130₹197.02₹153.97₹62.30₹71.65
% Change-5.00%-3.39%1.00%-0.57%-4.55%-0.46%
Revenue TTM (₹ Cr)-₹603.71₹458.28₹302.78₹680.05₹2,328.94
Net Profit TTM (₹ Cr)-₹29.25₹29.53₹32.05₹38.21₹84.38
PE TTM-28.8034.8012.8010.4011.50
1 Year Return-35.3631.07-39.4962.15-43.36-9.61
ROCE11.81-23.3424.0517.843.73

FAQ's on TATVA

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy